# Phase 3.4 Review Report — HIGH-urgency batch 2 (8 cards)

**Date**: 2026-05-29 · Upgraded prompt (mandatory dose/threshold verification table)

## Summary

| Card                     | Verdict      | Pass rate driver                             |
| ------------------------ | ------------ | -------------------------------------------- |
| SSP-GYN-06 HTA grossesse | **APPROVED** | MgSO4 + BP thresholds verified correct       |
| SSP-PUL-02 Hémoptysie    | **APPROVED** | massive-hemoptysis def + algorithm verified  |
| SSP-CAR-02 FA            | NEEDS_FIX    | WPW pre-excited AF omitted (critical)        |
| SSP-NEP-02 Colique       | NEEDS_FIX    | tamsulosine MET window, pyélo drainage delay |
| SSP-URG-02 Coma          | NEEDS_FIX    | naloxone cap, antibiotic intervals           |
| SSP-CAR-03 Syncope       | NEEDS_FIX    | DD frequency contradiction, POTS vs OH       |
| SSP-URG-12 Urg psy       | NEEDS_FIX    | serotonin syndrome missing                   |
| SSP-URG-03 ACR           | NEEDS_FIX    | defib energy phrasing, hypothermie RF        |

**APPROVED 2/8 (25%)** vs smoke test 1/5 (20%); verification tables cut false-positive fix noise.

## Fixes applied (with clinical ratification)

### CAR-02 (CRITICAL): added WPW pre-excited AF red flag — AV-nodal blockers (BB/digoxin/verapamil/diltiazem) can accelerate accessory-pathway conduction → VF. Tx: procaïnamide/amiodarone/DCCV. Also +4wk post-cardioversion anticoagulation; ESC-2024 CHA2DS2-VA note.

### NEP-02: tamsulosine MET → distal 5-10mm (EAU 2023); pyélo obstructive drainage → urgence <24h (the <6h was the torsion window, mis-applied); morphine bolus phrasing; amikacine /24h.

### URG-02: naloxone → titrate 0.04-0.4mg, no fixed 2mg cap; antibiotic intervals (aciclovir q8h, dexa q6h, amoxi q4h). REJECTED reviewer's "remove SYS-NEU" — forward-refs to future SYS cards are project convention.

### CAR-03: DD frequency — arrhythmic ~10-15% (was 35%, contradicted vasovagal 35%); HR rise ≥30 bpm relabeled POTS (not classic OH); QTc >460ms screening threshold added.

### URG-12: added serotonin syndrome red flag (clonus + hyperthermia under serotonergics → cyproheptadine); haloperidol-in-withdrawal pitfall; olanzapine IM + parenteral BZD safety; thiamine 200-500mg for Wernicke treatment.

### URG-03: defib → "≥150J (selon appareil), escalade 200-360J" (was fixed 200J); CPR post-lyse 60-90min; added hypothermie red flag ("not dead until warm and dead"); resolved confirmed markers.

### GYN-06 (APPROVED + promote): MgSO4 preferred 4g/1g·h; bétaméthasone <34+6 SA; markers → (protocole local:).

### PUL-02 (APPROVED + promote): +PCC/CCP for AVK reversal in massive bleed; TXA relative CI in EP-driven hemoptysis; markers → (protocole local:).

## Reviewer second-order accuracy

This batch's reviewer claims were nearly all ratifiable (vs smoke test where caffeine-salt, lactate-threshold, anaphylaxis-calcium needed correction). The verification-table format reduced — but the human ratification step still rejected 1 claim (SYS-NEU cartes_liees).
